Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has acquired the Pharmorphix® solid form research business from Sigma-Aldrich. This acquisition brings world-leading material science capabilities to Johnson Matthey’s expanding European API and clinical supply services.
Dr. Hans-Jürgen Rieger of Molnár-Institute gave a short lecture at the Eastern Analytical Symposium in Somerset, NJ last month. The talk focused on modeling of HPLC method robustness
Medical Research Network (MRN), the market leader in global home healthcare for clinical trials, has expanded further with a raft of new hires in the UK and US.
The Laupheim Biotech Days – formally known as Laupheimer Zelltage – provide a unique platform for the international exchange of knowledge, ideas and expertise. Held every two years, it focus on different topics in the field of biotechnology. A comprehensive overview is given and experts discuss cutting-edge technologies and techniques. Next year the 4th Laupheim Biotech Days will take place on June 13 to 14, 2016.
Change reflects the company’s evolution to a strategic partner, delivering data-driven digital and mobile health engagement campaigns that empower better decisions and drive business results.
The coldest place on earth is unsurprisingly the Antarctic, with temperatures regularly reaching minus 70 degrees Celsius. In research and industrial settings alike, the need for storing products and samples at ultra-low temperatures is constantly increasing. We are now able to replicate these bone-chilling temperatures in an innovative, efficient storage solution.
The stem cell disease model specialists join Chesterford’s Science Village community, taking space within the Park’s prestigious, ‘plug and play’ laboratory accommodation.
The stem cell disease model specialists, consolidate and ensure further commercial success by the recruitment of Sanj Kumar as Chief Business Officer.
New England Biolabs® (NEB®) announces the release of the NEBNext Library Quant Kit for Illumina®, a qPCR-based solution for accurate next generation sequencing library quantitation. This kit offers several improvements over other commercially available library quantitation methods, including greater accuracy and, consequently, higher correlation with cluster numbers, higher reproducibility, a more convenient protocol and supplied kit components.
New England Biolabs® (NEB) today announced the release of the NEBNext Ultra II DNA Library Prep Kit for Illumina® next generation sequencing systems. The new Ultra II kit substantially improves upon its predecessor to produce libraries of both higher quality and higher yield from a variety of sample types, including challenging ones, such as formalin-fixed, paraffin-embedded (FFPE) samples and those containing low amounts of input DNA.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.